171 related articles for article (PubMed ID: 33790913)
1. Group 3 Innate Lymphoid Cells Protect Steatohepatitis From High-Fat Diet Induced Toxicity.
Hamaguchi M; Okamura T; Fukuda T; Nishida K; Yoshimura Y; Hashimoto Y; Ushigome E; Nakanishi N; Majima S; Asano M; Yamazaki M; Takakuwa H; Kita M; Fukui M
Front Immunol; 2021; 12():648754. PubMed ID: 33790913
[No Abstract] [Full Text] [Related]
2. Trans Fatty Acid Intake Induces Intestinal Inflammation and Impaired Glucose Tolerance.
Okamura T; Hashimoto Y; Majima S; Senmaru T; Ushigome E; Nakanishi N; Asano M; Yamazaki M; Takakuwa H; Hamaguchi M; Fukui M
Front Immunol; 2021; 12():669672. PubMed ID: 33995404
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.
Tang Y; Bian Z; Zhao L; Liu Y; Liang S; Wang Q; Han X; Peng Y; Chen X; Shen L; Qiu D; Li Z; Ma X
Clin Exp Immunol; 2011 Nov; 166(2):281-90. PubMed ID: 21985374
[TBL] [Abstract][Full Text] [Related]
4. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice.
Furusho H; Miyauchi M; Hyogo H; Inubushi T; Ao M; Ouhara K; Hisatune J; Kurihara H; Sugai M; Hayes CN; Nakahara T; Aikata H; Takahashi S; Chayama K; Takata T
J Gastroenterol; 2013 Nov; 48(11):1259-70. PubMed ID: 23307045
[TBL] [Abstract][Full Text] [Related]
5. Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.
Luo X; Li H; Ma L; Zhou J; Guo X; Woo SL; Pei Y; Knight LR; Deveau M; Chen Y; Qian X; Xiao X; Li Q; Chen X; Huo Y; McDaniel K; Francis H; Glaser S; Meng F; Alpini G; Wu C
Gastroenterology; 2018 Dec; 155(6):1971-1984.e4. PubMed ID: 30213555
[TBL] [Abstract][Full Text] [Related]
6. Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice.
Li Y; Sun JP; Wang J; Lu WH; Xie LY; Lv J; Li HX; Yang SF
Biochem Biophys Res Commun; 2019 Aug; 516(3):858-865. PubMed ID: 31266632
[TBL] [Abstract][Full Text] [Related]
7. Immune modulating effects of additional supplementation of estradiol combined with testosterone in murine testosterone-deficient NAFLD model.
Okamura T; Hamaguchi M; Bamba R; Nakajima H; Yoshimura Y; Kimura T; Nishida K; Hashimoto Y; Fukuda T; Senmaru T; Fukui M
Am J Physiol Gastrointest Liver Physiol; 2020 Jun; 318(6):G989-G999. PubMed ID: 32363890
[TBL] [Abstract][Full Text] [Related]
8. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
Zhang X; Fan L; Wu J; Xu H; Leung WY; Fu K; Wu J; Liu K; Man K; Yang X; Han J; Ren J; Yu J
J Hepatol; 2019 Jul; 71(1):163-174. PubMed ID: 30914267
[TBL] [Abstract][Full Text] [Related]
9. Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.
Cruces-Sande M; Vila-Bedmar R; Arcones AC; González-Rodríguez Á; Rada P; Gutiérrez-de-Juan V; Vargas-Castrillón J; Iruzubieta P; Sánchez-González C; Formentini L; Crespo J; García-Monzón C; Martínez-Chantar ML; Valverde ÁM; Mayor F; Murga C
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3655-3667. PubMed ID: 30261289
[TBL] [Abstract][Full Text] [Related]
10. Clostridium butyricum B1 alleviates high-fat diet-induced steatohepatitis in mice via enterohepatic immunoregulation.
Zhou D; Pan Q; Liu XL; Yang RX; Chen YW; Liu C; Fan JG
J Gastroenterol Hepatol; 2017 Sep; 32(9):1640-1648. PubMed ID: 28109017
[TBL] [Abstract][Full Text] [Related]
11. Sodium fluorocitrate having inhibitory effect on fatty acid uptake ameliorates high fat diet-induced non-alcoholic fatty liver disease in C57BL/6J mice.
Hong SA; Jung IR; Choi SE; Hwang Y; Lee SJ; Son Y; Heo YJ; Cui R; Han SJ; Kim HJ; Lee KW; Kang Y
Sci Rep; 2019 Nov; 9(1):17839. PubMed ID: 31780766
[TBL] [Abstract][Full Text] [Related]
12. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
[TBL] [Abstract][Full Text] [Related]
13. Honokiol attenuates diet-induced non-alcoholic steatohepatitis by regulating macrophage polarization through activating peroxisome proliferator-activated receptor γ.
Zhong X; Liu H
J Gastroenterol Hepatol; 2018 Feb; 33(2):524-532. PubMed ID: 28670854
[TBL] [Abstract][Full Text] [Related]
14. Aging exacerbates high-fat diet-induced steatohepatitis through alteration in hepatic lipid metabolism in mice.
Ishizuka K; Kon K; Lee-Okada HC; Arai K; Uchiyama A; Yamashina S; Yokomizo T; Ikejima K
J Gastroenterol Hepatol; 2020 Aug; 35(8):1437-1448. PubMed ID: 32030821
[TBL] [Abstract][Full Text] [Related]
15. CXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic Steatohepatitis.
Tomita K; Freeman BL; Bronk SF; LeBrasseur NK; White TA; Hirsova P; Ibrahim SH
Sci Rep; 2016 Jun; 6():28786. PubMed ID: 27349927
[TBL] [Abstract][Full Text] [Related]
16. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.
Barreyro FJ; Holod S; Finocchietto PV; Camino AM; Aquino JB; Avagnina A; Carreras MC; Poderoso JJ; Gores GJ
Liver Int; 2015 Mar; 35(3):953-66. PubMed ID: 24750664
[TBL] [Abstract][Full Text] [Related]
17. Mesenteric adipose tissue B lymphocytes promote local and hepatic inflammation in non-alcoholic fatty liver disease mice.
Wu Z; Xu J; Tan J; Song Y; Liu L; Zhang F; Zhang Y; Li X; Chi Y; Liu Y
J Cell Mol Med; 2019 May; 23(5):3375-3385. PubMed ID: 30772951
[TBL] [Abstract][Full Text] [Related]
18. The role of hepassocin in the development of non-alcoholic fatty liver disease.
Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
[TBL] [Abstract][Full Text] [Related]
19. Glycine prevents metabolic steatohepatitis in diabetic KK-Ay mice through modulation of hepatic innate immunity.
Takashima S; Ikejima K; Arai K; Yokokawa J; Kon K; Yamashina S; Watanabe S
Am J Physiol Gastrointest Liver Physiol; 2016 Dec; 311(6):G1105-G1113. PubMed ID: 27659424
[TBL] [Abstract][Full Text] [Related]
20. Type 3 innate lymphoid cell: a new player in liver fibrosis progression.
Wang S; Li J; Wu S; Cheng L; Shen Y; Ma W; She W; Yang C; Wang J; Jiang W
Clin Sci (Lond); 2018 Dec; 132(24):2565-2582. PubMed ID: 30459204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
